Sacral nerve stimulation for bowel dysfunction following low anterior resection: a systematic review and meta-analysis.

Yeqian HuangC E Koh

Published in: Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland (2019)

Use of SNS may provide symptomatic benefits for patients with LARS refractory to medical therapy. However, the current level of evidence remains limited. A large multicentre study of SNS for LARS using the validated LARS score is warranted. In addition, the cost-effectiveness of SNS for patients with LARS needs further exploration.

Keyphrases

healthcare
oxidative stress
mesenchymal stem cells
bone marrow
cell therapy